< Back to companies
Nabla Bio

Nabla Bio

Cambridge, Massachusetts, United States

At Nabla, we’ve developed a protein engineering platform that makes it easier to design antibodies that are more likely to get FDA approved. We do this by learning the molecular properties that differentiate approved antibodies from ones that have failed.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.nabla.bio/
Only accessible to MedStartr community members. Join now

What do you think of Nabla Bio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now